For the Inventor, By the Inventor

Enter assignee name

Saitama Medical University

USPTO Granted Patents = 33

CIPO Patents = 2

EPO Patents = 18

Forward Citations = 22

Loading Chart...

Loading Chart...

70 inventors (with patents filed for the assignee):

Satoshi Inoue (5 out of 24 patents)

Takenobu Katagiri (4 out of 4 patents)

Sho Tsukamoto (4 out of 4 patents)

4. Shinnosuke Tsuji (4 out of 5 patents)

5. Kazuhiro Ikeda (4 out of 7 patents)

6. Kenji Osawa (3 out of 5 patents)

7. Yoshirou Kawaguchi (3 out of 4 patents)

8. Kensuke Nakamura (3 out of 39 patents)

9. Hiroshi Kagamu (3 out of 3 patents)

10. Tetsuya Uchida (3 out of 15 patents)

11. Masaaki Kawano (2 out of 14 patents)

12. Toru Yoshizawa (2 out of 6 patents)

13. Hiroshi Handa (2 out of 19 patents)

14. Masahiko Kato (2 out of 3 patents)

15. Hidemasa Kato (2 out of 3 patents)

33 patents: Sort by Forward Citations

1. 12442820 - Peripheral blood biomarker for evaluating anti-tumor immune effect of radiation therapy (2025-10-14),

2. 12298311 - Immunological biomarker for predicting clinical effect of cancer (2025-05-13),

3. 12159401 - Estimator learning device, estimator learning method, and estimator learning program (2024-12-03),

4. 11859006 - Method of treating ectopic ossification or diffuse intrinsic pontine glioma in a subject by administering an anti-ALK2 antibody (2024-01-02),

5. 11447554 - Anti-ALK2 antibody (2022-09-20),

6. 11312776 - Anti-ALK2 antibody (2022-04-26),

7. 11293924 - Immunological biomarker for predicting clinical effect of cancer (2022-04-05),

8. 10994007 - Immunity inducer (2021-05-04),

9. 10851342 - Method for producing pluripotent stem cells (2020-12-01),

10. 10835551 - Double-stranded nucleic acid molecule, DNA, vector, cancer cell growth inhibitor, cancer cell migration inhibitor, and drug (2020-11-17),

11. 10809200 - Test object visualizing device (2020-10-20),

12. 10561679 - Double-stranded nucleic acid molecule, DNA, vector, cancer cell growth inhibitor, cancer cell migration inhibitor, and drug (2020-02-18),

13. 10428148 - Anti-ALK2 antibody (2019-10-01),

14. 10413559 - Method for treating demyelinating disease (2019-09-17),

15. 10370730 - Detection method for mutation in 93rd amino acid of hepatitis C virus NS5A protein, and detection kit for mutation in 93rd amino acid of hepatitis C virus NS54 protein (2019-08-06),

Saitama Medical University is a prestigious educational institution located in Saitama, Japan. Established in 1982, the university offers a comprehensive range of medical and health-related programs, including undergraduate, graduate, and postgraduate courses. With a strong focus on cutting-edge research, Saitama Medical University is at the forefront of advancements in the healthcare sector. The university also boasts state-of-the-art facilities, a highly qualified faculty, and a collaborative environment for fostering innovation and excellence in medical education. For more information, visit their official website.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

33 Patents

#40 in Saitama 343-0827

#2,147 in Japan

#19,554 in the World

Saitama Medical University

Forward Citations = 22

70 inventors:

Satoshi Inoue (5 out of 24 patents)

Takenobu Katagiri (4 out of 4 patents)

Sho Tsukamoto (4 out of 4 patents)

4. Shinnosuke Tsuji (4 out of 5 patents)

5. Kazuhiro Ikeda (4 out of 7 patents)

Please report any incorrect information to support@idiyas.com

Loading…